These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28277191)

  • 21. Decreased miR-200a-3p is a key regulator of renal carcinoma growth and migration by directly targeting CBL.
    Ding M; Sun X; Zhong J; Zhang C; Tian Y; Ge J; Zhang CY; Zen K; Wang JJ; Zhang C; Wang C
    J Cell Biochem; 2018 Dec; 119(12):9974-9985. PubMed ID: 30171729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Depletion of the triggering receptor expressed on myeloid cells 2 inhibits progression of renal cell carcinoma via regulating related protein expression and PTEN-PI3K/Akt pathway.
    Zhang H; Sheng L; Tao J; Chen R; Li Y; Sun Z; Qian W
    Int J Oncol; 2016 Dec; 49(6):2498-2506. PubMed ID: 27779645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metastin inhibits migration and invasion of renal cell carcinoma with overexpression of metastin receptor.
    Shoji S; Tang XY; Umemura S; Itoh J; Takekoshi S; Shima M; Usui Y; Nagata Y; Uchida T; Osamura RY; Terachi T
    Eur Urol; 2009 Feb; 55(2):441-9. PubMed ID: 18395325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High Novel Oncogene with Kinase-Domain (NOK) Gene Expression is Associated with the Progression of Renal Cell Carcinoma.
    Cao Q; Chen M; Li Z; Huang W; Jin Y; Ye X; Tong M
    Clin Lab; 2016; 62(1-2):179-86. PubMed ID: 27012048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Orphan nuclear receptor COUP-TFII is an oncogenic gene in renal cell carcinoma.
    Fang X; Liu CX; Zeng XR; Huang XM; Chen WL; Wang Y; Ai F
    Clin Transl Oncol; 2020 May; 22(5):772-781. PubMed ID: 31368079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion.
    Henry C; Llamosas E; Knipprath-Meszaros A; Schoetzau A; Obermann E; Fuenfschilling M; Caduff R; Fink D; Hacker N; Ward R; Heinzelmann-Schwarz V; Ford C
    Oncotarget; 2015 Nov; 6(37):40310-26. PubMed ID: 26515598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined gene expression profiling and RNAi screening in clear cell renal cell carcinoma identify PLK1 and other therapeutic kinase targets.
    Ding Y; Huang D; Zhang Z; Smith J; Petillo D; Looyenga BD; Feenstra K; Mackeigan JP; Furge KA; Teh BT
    Cancer Res; 2011 Aug; 71(15):5225-34. PubMed ID: 21642374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal carcinoma/kidney progenitor cell chimera organoid as a novel tumorigenesis gene discovery model.
    Xu Q; Junttila S; Scherer A; Giri KR; Kivelä O; Skovorodkin I; Röning J; Quaggin SE; Marti HP; Shan J; Samoylenko A; Vainio SJ
    Dis Model Mech; 2017 Dec; 10(12):1503-1515. PubMed ID: 29084770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of MAPK kinase signaling pathways suppressed renal cell carcinoma growth and angiogenesis in vivo.
    Huang D; Ding Y; Luo WM; Bender S; Qian CN; Kort E; Zhang ZF; VandenBeldt K; Duesbery NS; Resau JH; Teh BT
    Cancer Res; 2008 Jan; 68(1):81-8. PubMed ID: 18172299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulated expression of eIF3C is associated with malignant behavior in renal cell carcinoma.
    Fan M; Wang K; Wei X; Yao H; Chen Z; He X
    Int J Oncol; 2019 Dec; 55(6):1385-1395. PubMed ID: 31638200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kindlin‑2 promotes clear cell renal cell carcinoma progression through the Wnt signaling pathway.
    Li M; Pei X; Wang G; Zhan J; Du J; Jiang H; Tang Y; Zhang H; He H
    Oncol Rep; 2017 Sep; 38(3):1551-1560. PubMed ID: 28677779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The interaction of YBX1 with G3BP1 promotes renal cell carcinoma cell metastasis via YBX1/G3BP1-SPP1- NF-κB signaling axis.
    Wang Y; Su J; Wang Y; Fu D; Ideozu JE; Geng H; Cui Q; Wang C; Chen R; Yu Y; Niu Y; Yue D
    J Exp Clin Cancer Res; 2019 Sep; 38(1):386. PubMed ID: 31481087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling.
    Enomoto M; Hayakawa S; Itsukushima S; Ren DY; Matsuo M; Tamada K; Oneyama C; Okada M; Takumi T; Nishita M; Minami Y
    Oncogene; 2009 Sep; 28(36):3197-208. PubMed ID: 19561643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.
    Li Y; Guan B; Liu J; Zhang Z; He S; Zhan Y; Su B; Han H; Zhang X; Wang B; Li X; Zhou L; Zhao W
    EBioMedicine; 2019 Jun; 44():439-451. PubMed ID: 31130475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitor of growth 4 inhibits cell proliferation, migration, and induces apoptosis of renal cell carcinoma cells.
    Sun J; Xie L; Lv J; Zhang W; Lv J; Liang Y; Geng Y; Li X
    J Cell Biochem; 2019 Apr; 120(4):6709-6717. PubMed ID: 30390334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p38gamma overexpression promotes renal cell carcinoma cell growth, proliferation and migration.
    Chen XF; Pan YS; Zheng B; Lu Q
    Biochem Biophys Res Commun; 2019 Aug; 516(2):466-473. PubMed ID: 31229268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclic AMP responsive element-binding protein induces metastatic renal cell carcinoma by mediating the expression of matrix metallopeptidase-2/9 and proteins associated with epithelial-mesenchymal transition.
    Wang X; Cui H; Lou Z; Huang S; Ren Y; Wang P; Weng G
    Mol Med Rep; 2017 Jun; 15(6):4191-4198. PubMed ID: 28487942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low expression of PDK1 inhibits renal cell carcinoma cell proliferation, migration, invasion and epithelial mesenchymal transition through inhibition of the PI3K-PDK1-Akt pathway.
    Zhou WM; Wu GL; Huang J; Li JG; Hao C; He QM; Chen XD; Wang GX; Tu XH
    Cell Signal; 2019 Apr; 56():1-14. PubMed ID: 30465826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ror2-Src signaling in metastasis of mouse melanoma cells is inhibited by NRAGE.
    Lai SS; Xue B; Yang Y; Zhao L; Chu CS; Hao JY; Wen CJ
    Cancer Genet; 2012 Nov; 205(11):552-62. PubMed ID: 23142633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR‑205 suppresses cell proliferation, invasion, and metastasis via regulation of the PTEN/AKT pathway in renal cell carcinoma.
    Wang H; Chen B; Duan B; Zheng J; Wu X
    Mol Med Rep; 2016 Oct; 14(4):3343-9. PubMed ID: 27498834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.